Analytical Data
-
基因名
FRMPD2
- Application
-
别名
FRMPD2; PDZD5C; PDZK4; PDZK5C; FERM and PDZ domain-containing protein 2; PDZ domain-containing protein 4; PDZ domain-containing protein 5C
-
种属
Human
-
表达系统
E. coli
-
标签
GST-tag at N-terminal
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q68DX3
-
表达区间
1-261aa
-
氨基酸序列
MGDERTAVSLVTALPGRPSSCVSVTDGPKFEVKLKKNANGLGFSFVQMEKESCSHLKSDLVRIKRLFPGQPAEENGAIAAGDIILAVNGRSTEGLIFQEVLHLLRGAPQEVTLLLCRPPPGALPELEQEWQTPELSADKEFTRATCTDSCTSPILDQEDSWRDSASPDAGEGLGLRPESSQKAIREAQWGQNRERPWASSLTHSPESHPHLCKLHQERDESTLATSLEKDVRQNCYSVCDIMRLGRYSFSSPLTRLSTDIF
-
分子量
55.2 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
FRMPD2, or FERM and PDZ domain-containing protein 2, is a member of the FERM and PDZ domain-containing proteins, which play crucial roles in cellular processes such as signaling, adhesion, and cytoskeletal organization. Research surrounding FRMPD2 has gained traction due to its involvement in various physiological and pathological processes, including neuronal development, synaptic signaling, and possibly in neurodegenerative diseases. The protein’s unique structural features facilitate interactions with other signaling molecules, making it a potential target for therapeutic interventions. In recent studies, FRMPD2 has been implicated in modulating the actin cytoskeleton, indicating its critical role in maintaining cell shape and motility. Given the importance of FRMPD2 in brain function and its potential links to disease mechanisms, understanding its molecular pathways and interactions is essential. The generation of recombinant FRMPD2 protein enables detailed exploration of its structure-function relationship, providing insights into its biological roles and paving the way for novel therapeutic strategies aimed at targeting its interactions in disease contexts.
